OCHSNER HEALTH SYSTEM
🇺🇸United States
Clinical Trials
54
Active:0
Completed:19
Trial Phases
4 Phases
Phase 1:2
Phase 2:6
Phase 4:9
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (40 trials with phase data)• Click on a phase to view related trials
Not Applicable
23 (57.5%)Phase 4
9 (22.5%)Phase 2
6 (15.0%)Phase 1
2 (5.0%)Cold and Compression Post TKA
Not Applicable
Not yet recruiting
- Conditions
- Primary Osteoarthritis Patients Scheduled for Total Knee Replacement Surgery
- First Posted Date
- 2025-06-15
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- Ochsner Health System
- Target Recruit Count
- 90
- Registration Number
- NCT07023185
- Locations
- 🇺🇸
Ochsner Medical Center - Kenner, New Orleans, Louisiana, United States
Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education
Not Applicable
Recruiting
- Conditions
- Pre-Eclampsia; Complicating PregnancyGestational Hypertension
- First Posted Date
- 2025-04-09
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Ochsner Health System
- Target Recruit Count
- 296
- Registration Number
- NCT06920563
- Locations
- 🇺🇸
Ochsner Baptist, New Orleans, Louisiana, United States
Colonoscopy and Antiplatelet Therapy Trial
Phase 4
Not yet recruiting
- Conditions
- Coronary Arterial Disease (CAD)Peripheral Vascular Disease
- Interventions
- Drug: P2Y12 inhibitor (clopidogrel, ticagrelor, prasugrel)
- First Posted Date
- 2024-09-25
- Last Posted Date
- 2024-09-25
- Lead Sponsor
- Ochsner Health System
- Target Recruit Count
- 100
- Registration Number
- NCT06613191
- Locations
- 🇺🇸
Ochsner Health, New Orleans, Louisiana, United States
90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia
Not Applicable
Recruiting
- Conditions
- Carcinoma, Hepatocellular
- First Posted Date
- 2023-07-20
- Last Posted Date
- 2023-11-14
- Lead Sponsor
- Ochsner Health System
- Target Recruit Count
- 50
- Registration Number
- NCT05953961
- Locations
- 🇺🇸
Ochsner Main Campus, New Orleans, Louisiana, United States
Combination Diuretic Therapy for Acute Decompensated Heart Failure
Phase 4
Withdrawn
- Conditions
- Acute Decompensated Heart Failure
- Interventions
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- Ochsner Health System
- Registration Number
- NCT05840536
- Locations
- 🇺🇸
Ochsner Heart and Vascular Institute, New Orleans, Louisiana, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
News
Battery-Free Sacral Neuromodulation Device Shows 84% Success Rate in Treating Urinary Incontinence
The Neuspera percutaneous sacral neuromodulation device demonstrated 84.2% efficacy in reducing urgent urinary leaks by at least 50% in a pivotal Phase 2 trial of 128 patients.